Anzeige
Mehr »
Donnerstag, 08.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Edison Investment Research

ZeitAktuelle NachrichtenRatingLeser
31.10.25International Public Partnerships - Responsible, growing and protected314International Public Partnerships (INPP) had a strong first half of 2025, maintaining solid financial and operational performance while advancing portfolio optimisation and disciplined capital allocation....
► Artikel lesen
31.10.25bp - bp updates Bumerangue513bp has provided an update on its hydrocarbon discovery at the Bumerangue block in the pre-salt Santos Basin, offshore Brazil. While the find was first reported in August, yesterday's confirmation of...
► Artikel lesen
30.10.25Georgia Capital - Portfolio growth accelerates283Georgia Capital (GCAP) reported strong Q325 results, with 7.9% quarterly growth in NAV per share (on a total return basis, in Georgian lari), continuing its long-term growth path (five-year NAV CAGR...
► Artikel lesen
30.10.25VEON - Q3 preview and changes to FY25 estimates876VEON has provided guidance on its Q325 results, which will be unusually complicated due to charges taken in relation to the Kyivstar listing and the loss on the sale of its 51% stake in Sky Mobile (Beeline)...
► Artikel lesen
30.10.25Primary Health Properties - A specialist REIT of scale563Primary Health Properties' (PHP's) £1.6bn accretive acquisition of Assura creates a sector specialist REIT of scale, strongly positioned to profitably deliver the investment that primary healthcare...
► Artikel lesen
30.10.25DUG Technology - Strong start to the year261DUG Technology reported Q126 year-on-year revenue growth of 19% and new services project awards growth of 9% y-o-y, maintaining a flat services order book versus end-FY25. Progress with international...
► Artikel lesen
30.10.25Filtronic - AGM update confirms trading in line302Filtronic's AGM trading update highlights a strong sales pipeline, rising engagement with both existing and new clients across key markets, and a robust order book. Despite fx headwinds from a weaker...
► Artikel lesen
30.10.25Datatec - ADR: Underlying EPS up 43% y-o-y353Datatec reported a strong performance for H126, with adjusted EBITDA growth of 22% y-o-y, adjusted EBITDA margin expansion from 5.9% to 7.0% and 43% growth in underlying EPS (uEPS) to 19.3c. Software...
► Artikel lesen
30.10.25Datatec - Underlying EPS up 43% y-o-y309Datatec reported a strong performance for H126, with adjusted EBITDA growth of 22% y-o-y, adjusted EBITDA margin expansion from 5.9% to 7.0% and 43% growth in underlying EPS (uEPS) to 19.3c. Software...
► Artikel lesen
29.10.25PVA TePla - Lower FY25 guidance but high order intake737On 24 October, PVA TePla (PVA) reported that project-related delays in the US and Asia, which had already led to lower FY25 sales and EBITDA guidance in Q2, persisted and worsened in Q3. Therefore,...
► Artikel lesen
28.10.25Foxtons Group - Lettings good, Sales held back short term342Foxtons Group's Q325 revenue growth was clearly affected by the loss of consumer confidence in the sales market. We, and the company, believe this will probably continue until the end of the year, given...
► Artikel lesen
28.10.25BB Biotech - Turning milestones into momentum850BB Biotech (BION) delivered strong Q325 results, underpinned by its focus on innovative biotech companies with differentiated clinical pipelines and promising long-term potential. NAV increased 24.0%...
► Artikel lesen
28.10.25Card Factory - It looks like a gift325Card Factory (CARD) made good progress on its strategy to become a leading global celebrations group in FY25. In the UK, further development of its product categories and space expansion led to market...
► Artikel lesen
28.10.25SynAct Pharma - Differentiated inflammation resolution approach269SynAct Pharma is focused on inflammation resolution therapeutics. Its lead asset, resomelagon, is differentiated by its novel mechanism, targeting specific melanocortin receptor subtypes believed to...
► Artikel lesen
27.10.25LM PAY - Beauty and health without waiting349LM PAY is a fintech providing consumer finance and 'care now, pay later' solutions via its B2B partnerships with beauty and medical facilities, allowing clients to pre-finance treatments. The company...
► Artikel lesen
27.10.25Zalaris - Debt refinanced, growth on track343Zalaris reported record revenue and adjusted EBIT in Q325, with continued growth in the Managed Services business more than offsetting a slower quarter for Zalaris Consulting. The company has secured...
► Artikel lesen
27.10.25Wheaton Precious Metals - Hunting Actaeon601Wheaton Precious Metals' (WPM's) Q325 financial results are scheduled for release on 6 November. Ahead of the announcement however, we already have production numbers from Salobo, Sudbury, Voisey's...
► Artikel lesen
24.10.25VEON - OLX acquisition adds to VEON's digital offering1.061VEON's Kazakh subsidiary, Beeline Kazakhstan, has agreed to acquire 100% of OLX Kazakhstan (OLX KZ) from OLX Group for a total consideration of $75m. OLX KZ is a leading online classifieds business...
► Artikel lesen
24.10.25IP Group - Pfizer-Metsera deal offers upside potential962There have been several announcements on technical and commercial progress across IP Group's portfolio this year. A recent highlight was Pfizer's announcement that it will acquire Metsera. IP Group...
► Artikel lesen
24.10.25Molten Ventures - Good momentum unfolding in H126341Molten Ventures expects to deliver a solid 7.2% NAV per share total return, according to its H126 trading update, supported by a 5.5% constant currency increase in gross portfolio value (driven by value-creation...
► Artikel lesen
24.10.25Record PLC - Highest level of reported AUM in Q226306Record reported steady progress in its Q226 trading update. Assets under management (AUM) grew by 2% in the quarter to $110.3bn, the highest level reported for Record, primarily driven by positive asset...
► Artikel lesen
24.10.25Actinogen Medical - XanaMIA recruitment exceeds expectations330Actinogen Medical reported that, due to recent accelerations in screening and enrolment for its Phase IIb/III XanaMIA study of lead candidate Xanamem in patients with mild-to-moderate Alzheimer's disease...
► Artikel lesen
23.10.25Northern Data Group - Q325 update and progress on strategic disposals667While Northern Data Group's Q325 trading update shows a steady improvement in operational metrics, they are not sufficient to support FY25 guidance and therefore the company has withdrawn them. Although...
► Artikel lesen
23.10.25Lowland Investment Company - Another year of strong outperformance259Lowland Investment Company's (LWI's) unconstrained, multi-cap investment policy differentiates it from most peers in the AIC UK Equity Income sector, offering investors broad market exposure outside...
► Artikel lesen
23.10.25Freelancer Limited - Stable performance in Q3233Freelancer reported essentially flat revenues in Q325 on a lower gross marketplace volume (GMV). Higher take rates in Escrow.com more than compensated for lower volumes, essentially offsetting a small...
► Artikel lesen